Dadun/></a>
				</td>
				<td class= Dadun
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Oncología > Oncología molecular > DA - CIMA - Oncología - Oncología molecular - Artículos de Revista >

Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes
Authors: Rubio-Moscardo, F. (Fanny)
Blesa, D. (David)
Mestre, C. (Cinta)
Siebert, R. (Reiner)
Balasas, T. (T.)
Benito, A. (Alberto)
Rosenwald, A. (Andreas)
Climent, J. (J.)
Martinez, J.I. (José I.)
Schilhabel, M. (Markus)
Karran, E. (E.L.)
Gesk, S. (Stefan)
Esteller, M. (Manel)
DeLeeuw, R. (R.)
Staudt, L.M. (Louis M.)
Fernandez-Luna, J.L. (J. L.)
Pinkel, D. (Daniel)
Dyer, M.J.S. (Martin J. S.)
Martinez-Climent, J.A. (José Angel)
Keywords: Lymphoma, B-Cell
Genes, Tumor Suppressor
Issue Date: 2005
Publisher: American Society of Hematology
Publisher version: http://bloodjournal.hematologylibrary.org/content/106/9/3214
ISSN: 1528-0020
Citation: Rubio-Moscardo F, Blesa D, Mestre C, Siebert R, Balasas T, Benito A, et al. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. Blood 2005 Nov 1;106(9):3214-3222
Abstract
Deletions of chromosome 8p are a recurrent event in B-cell non-Hodgkin lymphoma (B-NHL), suggesting the presence of a tumor suppressor gene. We have characterized these deletions using comparative genomic hybridization to microarrays, fluorescence in situ hybridization (FISH) mapping, DNA sequencing, and functional studies. A minimal deleted region (MDR) of 600 kb was defined in chromosome 8p21.3, with one mantle cell lymphoma cell line (Z138) exhibiting monoallelic deletion of 650 kb. The MDR extended from bacterial artificial chromosome (BAC) clones RP11-382J24 and RP11-109B10 and included the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor gene loci. Sequence analysis of the individual expressed genes within the MDR and DNA sequencing of the entire MDR in Z138 did not reveal any mutation. Gene expression analysis and quantitative reverse transcriptase-polymerase chain reaction (QRT-PCR) showed down-regulation of TRAIL-R1 and TRAIL-R2 receptor genes as a consistent event in B-NHL with 8p21.3 loss. Epigenetic inactivation was excluded via promoter methylation analysis. In vitro studies showed that TRAIL-induced apoptosis was dependent on TRAIL-R1 and/or -R2 dosage in most tumors. Resistance to apoptosis of cell lines with 8p21.3 deletion was reversed by restoration of TRAIL-R1 or TRAIL-R2 expression by gene transfection. Our data suggest that TRAIL-R1 and TRAIL-R2 act as dosage-dependent tumor suppressor genes whose monoallelic deletion can impair TRAIL-induced apoptosis in B-cell lymphoma.
Permanent link: http://hdl.handle.net/10171/17901
Appears in Collections:DA - CIMA - Oncología - Oncología molecular - Artículos de Revista

Files in This Item:
File:  3214.full.pdf
Description: 
Size:  654,65 kB
Format:  Adobe PDF
 View / Open 

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.